IL163763A0 - Induction method for cell differentiation - Google Patents

Induction method for cell differentiation

Info

Publication number: IL163763A0
Authority: IL; Israel
Prior art keywords: group; cooh; cell differentiation; hydrocarbyl substituted; membered
Prior art date: 2002-02-28

Application number

IL16376303A

Other languages

English (en)

Original Assignee

Vladimir Evgenievich Nebolsin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-28

Filing date

2003-02-28

Publication date

2005-12-18

2003-02-28 Application filed by Vladimir Evgenievich Nebolsin filed Critical Vladimir Evgenievich Nebolsin

2005-12-18 Publication of IL163763A0 publication Critical patent/IL163763A0/xx

Links

230000024245 cell differentiation Effects 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 3
230000006698 induction Effects 0.000 title 1
125000000896 monocarboxylic acid group Chemical group 0.000 abstract 4
125000004442 acylamino group Chemical group 0.000 abstract 3
125000000623 heterocyclic group Chemical group 0.000 abstract 3
125000001183 hydrocarbyl group Chemical group 0.000 abstract 3
241000124008 Mammalia Species 0.000 abstract 2
230000001939 inductive effect Effects 0.000 abstract 2
210000002780 melanosome Anatomy 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
KZIMLUFVKJLCCH-UHFFFAOYSA-N 5-[2-(1h-imidazol-5-yl)ethylamino]-5-oxopentanoic acid Chemical compound OC(=O)CCCC(=O)NCCC1=CNC=N1 KZIMLUFVKJLCCH-UHFFFAOYSA-N 0.000 abstract 1
241000699660 Mus musculus Species 0.000 abstract 1
125000003368 amide group Chemical group 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
-1 cyclic imide Chemical class 0.000 abstract 1
239000000824 cytostatic agent Substances 0.000 abstract 1
230000001085 cytostatic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000003304 gavage Methods 0.000 abstract 1
239000000411 inducer Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
201000001441 melanoma Diseases 0.000 abstract 1
238000011580 nude mouse model Methods 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

IL16376303A 2002-02-28 2003-02-28 Induction method for cell differentiation IL163763A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
RU2002105392/14A RU2217196C2 (ru)	2002-02-28	2002-02-28	Способ индукции дифференцировки клеток
PCT/RU2003/000072 WO2003072124A1 (en)	2002-02-28	2003-02-28	Induction method for cell differentiation

Publications (1)

Publication Number	Publication Date
IL163763A0 true IL163763A0 (en)	2005-12-18

Family

ID=27764932

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL16376303A IL163763A0 (en)	2002-02-28	2003-02-28	Induction method for cell differentiation
IL163763A IL163763A (en)	2002-02-28	2004-08-26	A method of inspiring cell division
IL209653A IL209653A0 (en)	2002-02-28	2010-11-30	Peptide derivatives

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL163763A IL163763A (en)	2002-02-28	2004-08-26	A method of inspiring cell division
IL209653A IL209653A0 (en)	2002-02-28	2010-11-30	Peptide derivatives

Country Status (18)

Country	Link
US (1)	US7759313B2 (de)
EP (1)	EP1491206B9 (de)
JP (1)	JP4711626B2 (de)
CN (1)	CN1649612B (de)
AT (1)	ATE488234T1 (de)
AU (1)	AU2003235538A1 (de)
CY (1)	CY1111265T1 (de)
DE (1)	DE60334978D1 (de)
DK (1)	DK1491206T3 (de)
EA (1)	EA007474B1 (de)
ES (1)	ES2356308T3 (de)
HK (1)	HK1079990B (de)
IL (3)	IL163763A0 (de)
PT (1)	PT1491206E (de)
RU (1)	RU2217196C2 (de)
SI (1)	SI1491206T1 (de)
UA (1)	UA85039C2 (de)
WO (1)	WO2003072124A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MC200060A1 (fr) *	2002-10-04	2003-05-28	M Exsymol Sa	Produit de couplage entre la tryptamine et un alpha-aminoacide son procédé de préparation et son application dans le domaine de la neuro-cosmétique
RU2335495C2 (ru) *	2005-06-15	2008-10-10	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	N-ацильные производные аминокислот, их фармацевтически приемлевые соли, фармацевтическая композиция и применение в качестве гиполипидемических средств
RU2406727C2 (ru) *	2008-02-13	2010-12-20	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Фармацевтическая композиция, содержащая n-ацильные производные аминокислот, и их применение в качестве противоаллергических, антианафилактических и противовоспалительных средств
RU2378284C2 (ru) *	2008-02-13	2010-01-10	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Способы получения n-ацильных производных аминокислот (варианты)
RU2373934C1 (ru)	2008-03-19	2009-11-27	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
RU2359030C1 (ru) *	2008-03-19	2009-06-20	Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий"	Способ получения эндотелиальных клеток из эмбриональных стволовых клеток человека (варианты)
JP5370957B2 (ja) *	2008-08-20	2013-12-18	学校法人日本大学	アポトーシス抑制剤
ES2670618T3 (es) *	2010-10-22	2018-05-31	Corum Inc.	Derivados de glicina que inhiben la producción de melanina y composición de blanqueamiento de los mismos
CN104257515B (zh) *	2010-10-22	2017-05-03	新钰生技股份有限公司	具有抑制黑色素生成的甘胺酸衍生物及使用其的美白组成物
UA115431C2 (uk) *	2011-10-11	2017-11-10	Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт"	Застосування глутарилгістаміну для лікування захворювань дихальних шляхів
CN103382179A (zh) *	2013-06-05	2013-11-06	四川百利药业有限责任公司	英加韦林的多晶型物及其制备方法
RU2628800C2 (ru) *	2014-03-12	2017-08-22	Общество С Ограниченной Ответственностью "Фарминтерпрайсез"	Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
CN112770743A (zh) *	2018-09-25	2021-05-07	美洛治疗有限公司	用于在与暴露于致命辐射相关症状的治疗中使用的咪唑基乙酰胺戊二酸
RU2726119C1 (ru) *	2019-11-22	2020-07-09	Общество С Ограниченной Ответственностью "Валента - Интеллект"	Новые производные полиолов, их применение, фармацевтическая композиция на их основе

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6016926A (ja) *	1983-07-06	1985-01-28	Kaneshiro Nagai	抗腫瘍剤
JPS6016934A (ja) *	1983-07-06	1985-01-28	Kaneshiro Nagai	抗腫瘍剤
US4816442A (en) *	1986-11-07	1989-03-28	Collagen Corporation	Method of inhibiting tumor growth sensitive to CIF-βtreatment
JPS6442430A (en) *	1987-08-11	1989-02-14	Nippon Univ	Side effect remover for chemotherapeutic agent
US5350836A (en) *	1989-10-12	1994-09-27	Ohio University	Growth hormone antagonists
JPH0585942A (ja) *	1991-02-26	1993-04-06	Denki Kagaku Kogyo Kk	インターフエロン−ヒアルロン酸及び／又はその塩の結合体
CA2108584C (en) *	1992-10-27	1998-11-24	James B. Doherty	Substituted azetidinones as anti-inflammatory and antidegenerative agents
GB9308695D0 (en) *	1993-04-27	1993-06-09	Celltech Ltd	Peptidyl derivatives
IL110296A (en) *	1993-07-16	1999-12-31	Smithkline Beecham Corp	Imidazole compounds process for their preparation and pharmaceutical compositions containing them
RO115498B1 (ro)	1993-10-29	2000-03-30	Univ Boston	Metoda de tratament a neoplasmului
JP3517274B2 (ja)	1994-05-20	2004-04-12	株式会社ナリス化粧品	皮膚組成物
RU2120298C1 (ru) *	1995-11-28	1998-10-20	Товарищество с ограниченной ответственностью "Верта"	Иммуностимулятор и препарат на его основе
FR2762315B1 (fr) *	1997-04-22	1999-05-28	Logeais Labor Jacques	Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha
RU2141483C1 (ru)	1997-07-04	1999-11-20	Небольсин Владимир Евгеньевич	Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
JP2001522811A (ja) *	1997-11-07	2001-11-20	マヨファウンデーションフォーメディカルエデュケーションアンドリサーチ	インターフェロン免疫療法
US6838436B1 (en) *	1998-07-10	2005-01-04	Osteoscreen Inc.	Inhibitors of proteasomal activity for stimulating bone growth
WO2000020576A2 (en)	1998-10-02	2000-04-13	The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services, The National Institutes Of Health	Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein

2002
- 2002-02-28 RU RU2002105392/14A patent/RU2217196C2/ru not_active IP Right Cessation
2003
- 2003-02-28 SI SI200331938T patent/SI1491206T1/sl unknown
- 2003-02-28 CN CN038094959A patent/CN1649612B/zh not_active Expired - Lifetime
- 2003-02-28 DE DE60334978T patent/DE60334978D1/de not_active Expired - Lifetime
- 2003-02-28 IL IL16376303A patent/IL163763A0/xx unknown
- 2003-02-28 US US10/505,976 patent/US7759313B2/en not_active Expired - Lifetime
- 2003-02-28 PT PT03743087T patent/PT1491206E/pt unknown
- 2003-02-28 DK DK03743087.3T patent/DK1491206T3/da active
- 2003-02-28 AU AU2003235538A patent/AU2003235538A1/en not_active Abandoned
- 2003-02-28 AT AT03743087T patent/ATE488234T1/de active
- 2003-02-28 ES ES03743087T patent/ES2356308T3/es not_active Expired - Lifetime
- 2003-02-28 JP JP2003570868A patent/JP4711626B2/ja not_active Expired - Lifetime
- 2003-02-28 EP EP03743087A patent/EP1491206B9/de not_active Expired - Lifetime
- 2003-02-28 WO PCT/RU2003/000072 patent/WO2003072124A1/ru not_active Ceased
- 2003-02-28 EA EA200401105A patent/EA007474B1/ru unknown
- 2003-02-28 UA UA20040907835A patent/UA85039C2/uk unknown
- 2003-02-28 HK HK06100072.5A patent/HK1079990B/zh not_active IP Right Cessation
2004
- 2004-08-26 IL IL163763A patent/IL163763A/en active IP Right Grant
2010
- 2010-11-30 IL IL209653A patent/IL209653A0/en unknown
2011
- 2011-02-09 CY CY20111100154T patent/CY1111265T1/el unknown

Also Published As

Publication number	Publication date
PT1491206E (pt)	2011-02-11
ATE488234T1 (de)	2010-12-15
CN1649612A (zh)	2005-08-03
HK1079990A1 (en)	2006-04-21
SI1491206T1 (sl)	2011-03-31
AU2003235538A1 (en)	2003-09-09
EA200401105A1 (ru)	2004-12-30
HK1079990B (zh)	2011-12-09
JP2005532269A (ja)	2005-10-27
EP1491206A1 (de)	2004-12-29
WO2003072124A1 (en)	2003-09-04
EP1491206A4 (de)	2006-01-11
EP1491206B1 (de)	2010-11-17
IL163763A (en)	2011-12-29
JP4711626B2 (ja)	2011-06-29
EA007474B1 (ru)	2006-10-27
IL209653A0 (en)	2011-02-28
ES2356308T3 (es)	2011-04-06
US20050180953A1 (en)	2005-08-18
CY1111265T1 (el)	2015-08-05
UA85039C2 (uk)	2008-12-25
EP1491206B9 (de)	2011-03-09
DK1491206T3 (da)	2011-03-14
US7759313B2 (en)	2010-07-20
DE60334978D1 (de)	2010-12-30
CN1649612B (zh)	2011-04-06
RU2217196C2 (ru)	2003-11-27

Publication	Publication Date	Title
IL209653A0 (en)	2011-02-28	Peptide derivatives
TW332201B (en)	1998-05-21	1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
ATE360419T1 (de)	2007-05-15	Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
PL322619A1 (en)	1998-02-02	Pharmaceutic composition containing the proton-pump inhibitors
NZ330216A (en)	2000-09-29	Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
ATE204583T1 (de)	2001-09-15	Menschliche monocyte chemoattractantia proteine-1 (mcp) derivaten
TW345575B (en)	1998-11-21	Pharmaceutical composition comprising an inhibitor for ras farnesylation and the preparation of the inhibitor compound
DK0660707T3 (da)	2001-10-01	Amantadin og beslægtede forbindelser til anvendelse i behandlingen af perifer neuropati
DK1077691T3 (da)	2008-10-27	Gammaaminosmörsyre-derivater indeholdende faste sammensætninger og fremgangsmåde til fremstilling heraf
EA200100905A1 (ru)	2002-02-28	Фармацевтическая композиция, содержащая ингибиторы протонного насоса
RU2002120462A (ru)	2004-01-10	Замещенные производные N-бензилиндол-3-ил-глиоксиловой кислоты, обладающие противоопухолевым действием (варианты), их кислотно-аддитивные соли и их применение (варианты), фармацевтический препарат, лекарственная форма
EA200100791A1 (ru)	2002-04-25	Ингибиторы аминотрансфераз, зависимых от аминокислот с разветвленной цепью, и их применение в лечении диабетической ретинопатии
NO20003313D0 (no)	2000-06-23	Terapeutiske midler
EP0813409A4 (de)	1999-01-07	Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
TW355709B (en)	1999-04-11	Quinoline carboxylic acid derivative
DK0783495T3 (da)	2002-04-22	Quinoxalinderivater, der er egnede i terapi
NO894720L (no)	1990-01-29	Farmasoeytisk aktivt protein.
ZA958708B (en)	1996-05-14	Pharmaceutical composition for prophylaxis and treatment of Type I allergic diseases
DK628388D0 (da)	1988-11-10	Vincristinholdigt produkt
MX9710257A (es)	1998-03-29	Azepanes novedosos y sus homologos de anillo para terapia y profilaxis de enfermedades mediadas por proteina cinasa.
IT1256699B (it)	1995-12-12	Sali dell'estere metossimetilico della anfotericina b.